Sensibio DS+ crème

> CLINICAL RESULTS
Sensibio DS+ crème significantly purifies the skin (fungistatic activity against Malassezia furfur and Malassezia globosa ⁽¹⁾, two specific species involved in seborrheic dermatitis) and significantly increases the skin hydration level during 8h after application (+19%* 8h after use) ⁽²⁾

ACTION ON SEBORRHEIC DERMATITIS
After 56 days of use on the face, Sensibio DS+ crème in patients suffering from seborrheic dermatitis crème significantly decreases: ⁽³⁾

• Erythema (-81.9%) *
• Pruritus (-88.4%) *
• Overheating sensation (-90.3%) *
• Scales (-93.1%) *
• Tightness sensation (-91.8%) *

After 2 months, Sensibio DS+ Crème, in 100% of cases, led to either a total disappearance in lesions (58%) or a significant improvement of SD lesions (42%) according to the helathcare provider ⁽³⁾

Quality of life was significantly improved (-91.4%*** of scorage of social impact) with a significant overall improvement of symptoms of seborrheic dermatitis.⁽³⁾

TOLERANCE
Sensibio DS+ crème demonstrated a very good tolerance. No clinical sign was observed by the investigator after 28 days of use of Sensibio DS+ crème ⁽⁴⁾
Moreover, Sensibio DS+ crème did not induce any significant increase in the number of acne elements ⁽⁴⁾

* p<0.001, Wilcoxon test, after 56 days

> PATIENTS FEEDBACKS
After 21 days of use, for more than 91% of them, the skin is soothed, hydrated and the product restores skin comfort.⁽⁵⁾

For 100% of subjects, the product is easy and pleasant to apply with no residual or sticky film ⁽⁵⁾

More than 90% of patients with Seborrheic Dermatitis of the face found that Sensitive DS+ crème has a refreshing effect and quickly absorbed. ⁽⁶⁾

(1) Evaluation of fungistatic activity of Sensibio DS+ crème against Malassezia furfur and globosa after 3 days of cultivation of species with the product
(2) Evaluation of cutation hydration rate by corneometric of Sensibio DS+ crème – 11 volunteers (aged 18 – 58 years old) with very dry skin with a single application.
(3) Evaluation and tolerance assessment of Sensibio DS+ crème – 363 patients (aged 18 – 91 years old) with mild to moderate Seborrheic Dermatitis with twice daily application.
(4) Evaluation of the local cutaneous safety and non-comedogenicity of Sensibio DS+ crème – 21 volunteers (aged 21 – 62 years) with sensitive or oily skin with once or twice a day.
(5) User test on Sensibio DS+ crème – 22 volunteers (aged 26 – 69 years old) with sensitive skin with twice application.
(6) User test on Sensibio DS+ crème – 363 volunteers (aged 18 – 91 years old) with mild to moderate Seborrheic Dermatitis with twice application.